Enanta Pharmaceuticals, Inc. (ENTA)

Looking to buy Enanta Pharmaceuticals Stock? Get the latest ENTA quote, news, earnings, forecast, price targets, and market insights. Start investing on Public.com.

Enanta Pharmaceuticals (ENTA) delivered earnings and revenue surprises of +2.17% and -2.26%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Enanta Pharmaceuticals (ENTA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Investing.com - Enanta (NASDAQ: ENTA) reported second quarter EPS of $-0.45, $0.12 better than the analyst estimate of $-0.57. Revenue for the quarter came in at $17.2M versus the consensus estimate of $16.75M. Enanta’s stock price closed at $15.46. It is up 11.71% in the last 3 months and up 178.56…

The company reported earnings of -$0.45 per share, beating estimates of -$0.50 by $0.05. The company also reported revenue of $17,160,000, missing estimates of $17,433,840 by $-273,840.You can see Quiver Quantitative's $ENTA stock page to track data on insider trading, hedge fund activity, ...